AAAAAA

   
Results: 1-25 | 26-29
Results: 1-25/29
The importance of 24-h blood pressure control
Authors: Neutel, JM
Citation: Jm. Neutel, The importance of 24-h blood pressure control, BL PRESS M, 6(1), 2001, pp. 9-16
Beyond the sphygmomanometric numbers: Hypertension as a syndrome
Authors: Neutel, JM
Citation: Jm. Neutel, Beyond the sphygmomanometric numbers: Hypertension as a syndrome, AM J HYPERT, 14(8), 2001, pp. 250S-257S
Efficacy of candesartan cilexetil as add-on therapy in hypertensive patients uncontrolled on background therapy: A clinical experience trial
Authors: Weir, MR Weber, MA Neutel, JM Vendetti, J Michelson, EL Wang, RY
Citation: Mr. Weir et al., Efficacy of candesartan cilexetil as add-on therapy in hypertensive patients uncontrolled on background therapy: A clinical experience trial, AM J HYPERT, 14(6), 2001, pp. 567-572
New blood pressure goals: The importance of combination therapy - Introduction
Authors: Neutel, JM
Citation: Jm. Neutel, New blood pressure goals: The importance of combination therapy - Introduction, AM J HYPERT, 14(5), 2001, pp. 1S-2S
Low-dose combination therapy: An important first-line treatment in the management of hypertension
Authors: Neutel, JM Smith, DHG Weber, MA
Citation: Jm. Neutel et al., Low-dose combination therapy: An important first-line treatment in the management of hypertension, AM J HYPERT, 14(3), 2001, pp. 286-292
Arterial compliance abnormalities in isolated systolic hypertension
Authors: Beltran, A McVeigh, G Morgan, D Glasser, SP Neutel, JM Weber, M Finkelstein, SM Cohn, JN
Citation: A. Beltran et al., Arterial compliance abnormalities in isolated systolic hypertension, AM J HYPERT, 14(10), 2001, pp. 1007-1011
A new chronotherapeutic oral drug absorption system for verapamil optimizes blood pressure control in the morning
Authors: Smith, DHG Neutel, JM Weber, MA
Citation: Dhg. Smith et al., A new chronotherapeutic oral drug absorption system for verapamil optimizes blood pressure control in the morning, AM J HYPERT, 14(1), 2001, pp. 14-19
Ambulatory blood pressure monitoring to assess the comparative efficacy and duration of action of a novel new angiotensin II receptor blocker-telmisartan
Authors: Neutel, JM
Citation: Jm. Neutel, Ambulatory blood pressure monitoring to assess the comparative efficacy and duration of action of a novel new angiotensin II receptor blocker-telmisartan, BLOOD PRESS, 10, 2001, pp. 27-32
Contrasting clinical properties and exercise responses in obese and lean hypertensive patients
Authors: Weber, MA Neutel, JM Smith, DHG
Citation: Ma. Weber et al., Contrasting clinical properties and exercise responses in obese and lean hypertensive patients, J AM COL C, 37(1), 2001, pp. 169-174
Clinical studies of CS-866, the newest angiotensin II receptor antagonist
Authors: Neutel, JM
Citation: Jm. Neutel, Clinical studies of CS-866, the newest angiotensin II receptor antagonist, AM J CARD, 87(8A), 2001, pp. 37C-43C
Genetics in hypertension
Authors: Neutel, JM Smith, DHG
Citation: Jm. Neutel et Dhg. Smith, Genetics in hypertension, CUR CL PRAC, 2001, pp. 33-46
Rationale for low-dose combination therapy in cardiovascular risk management
Authors: Neutel, JM Smith, DHG
Citation: Jm. Neutel et Dhg. Smith, Rationale for low-dose combination therapy in cardiovascular risk management, CUR CL PRAC, 2001, pp. 231-243
Use of ambulatory blood pressure monitoring to evaluate the selective angiotensin II receptor antagonist, telmisartan, and other antihypertensive drugs
Authors: Neutel, JM
Citation: Jm. Neutel, Use of ambulatory blood pressure monitoring to evaluate the selective angiotensin II receptor antagonist, telmisartan, and other antihypertensive drugs, BL PRESS M, 5, 2000, pp. S35-S40
Differing roles of body mass and the renin-angiotensin system in mediatingthe hypertension syndrome
Authors: Weber, MA Smith, DHG Neutel, JM
Citation: Ma. Weber et al., Differing roles of body mass and the renin-angiotensin system in mediatingthe hypertension syndrome, AM J NEPHR, 20(3), 2000, pp. 169-174
Efficacy of valsartan in patients aged >= 65 years with systolic hypertension
Authors: Neutel, JM Bedigian, MP
Citation: Jm. Neutel et Mp. Bedigian, Efficacy of valsartan in patients aged >= 65 years with systolic hypertension, CLIN THER, 22(8), 2000, pp. 961-969
Implications of a health lifestyle and medication analysis for improving hypertension control
Authors: Weir, MR Maibach, EW Bakris, GL Blach, HR Chawla, P Messerli, FH Neutel, JM Weber, MA
Citation: Mr. Weir et al., Implications of a health lifestyle and medication analysis for improving hypertension control, ARCH IN MED, 160(4), 2000, pp. 481-490
The efficacy and safety of telmisartan compared to enalapril in patients with severe hypertension
Authors: Neutel, JM Smith, DHG Reilly, PA
Citation: Jm. Neutel et al., The efficacy and safety of telmisartan compared to enalapril in patients with severe hypertension, INT J CL PR, 53(3), 1999, pp. 175-178
The role of combination therapy in achieving blood pressure control
Authors: Neutel, JM
Citation: Jm. Neutel, The role of combination therapy in achieving blood pressure control, AM J M CARE, 5(7), 1999, pp. S463-S468
Perindopril: Clinical profile of a unique ACE inhibitor
Authors: Neutel, JM
Citation: Jm. Neutel, Perindopril: Clinical profile of a unique ACE inhibitor, AM J M CARE, 5(12), 1999, pp. S728-S737
Issues in vascular compliance
Authors: Weber, MA Safar, ME Cohn, JN Izzo, JL Neutel, JM
Citation: Ma. Weber et al., Issues in vascular compliance, AM J M CARE, 5(12), 1999, pp. S738-S745
Low-dose antihypertensive combination therapy: Its rationale and role in cardiovascular risk management
Authors: Neutel, JM
Citation: Jm. Neutel, Low-dose antihypertensive combination therapy: Its rationale and role in cardiovascular risk management, AM J HYPERT, 12(8), 1999, pp. 73S-79S
From hypertension to heart disease: Interfering with progression - Introduction and overview
Authors: Neutel, JM
Citation: Jm. Neutel, From hypertension to heart disease: Interfering with progression - Introduction and overview, AM J HYPERT, 12(12), 1999, pp. 179S-180S
Is high blood pressure a late manifestation of the hypertension syndrome?
Authors: Neutel, JM Smith, DHG Weber, MA
Citation: Jm. Neutel et al., Is high blood pressure a late manifestation of the hypertension syndrome?, AM J HYPERT, 12(12), 1999, pp. 215S-223S
From hypertension to heart disease: Interfering with progression
Authors: Neutel, JM
Citation: Jm. Neutel, From hypertension to heart disease: Interfering with progression, AM J HYPERT, 12(12), 1999, pp. 149S-149S
Hypertension control: Multifactorial contributions
Authors: Neutel, JM Smith, DHG
Citation: Jm. Neutel et Dhg. Smith, Hypertension control: Multifactorial contributions, AM J HYPERT, 12(12), 1999, pp. 164S-169S
Risultati: 1-25 | 26-29